SELEGILINE HYDROCHLORIDE (DAVA Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the SELEGILINE HYDROCHLORIDE drug offered from DAVA Pharmaceuticals, Inc.. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | DAVA Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | SELEGILINE HYDROCHLORIDE |
SUBSTANCE NAME: | SELEGILINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2006-11-04 |
END MARKETING DATE: | 0000-00-00 |
SELEGILINE HYDROCHLORIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | SELEGILINE HYDROCHLORIDE from DAVA Pharmaceuticals, Inc. |
LABELER NAME: | DAVA Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2006-11-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67253-700_1506c0d8-a0a8-4917-9d38-a78244c172cc |
PRODUCT NDC: | 67253-700 |
APPLICATION NUMBER: | ANDA075352 |
Other SELEGILINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: